Macro Trials offers a turnkey, digitally powered clinical research platform built around a distributed hub-and-spoke model that supports in-person and decentralized trials. The platform equips physician groups and independent clinicians with workflow-native efficiency tools, clinical research personnel, logistics partners, and real-time data collection and management. Macro aggregates and synthesizes proprietary real-world evidence to create longitudinal patient records and accelerate research velocity. The company emphasizes equitable enrollment and reports strong diversity metrics from its early trials: more than 75% female participants (vs. 41% industry standard), age disparity under one year (vs. typical 7–10 years), and 46% Hispanic participants (vs. ~6% typical). Macro plans to continue product development, expand clinical trial infrastructure across geographies and therapeutic areas, and scale its study execution and data generation flywheel. The company announced $6 million in seed funding to support those efforts.

Total raised

$6M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2023